Fabienne Steens
Chief Investment Officer at Biomedical Diagnostics NV
Profile
Fabienne Steens has worked as the Managing Director & Director at Biomedical Diagnostics NV since 2003.
Fabienne Steens active positions
Companies | Position | Start |
---|---|---|
Biomedical Diagnostics NV
Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Chief Investment Officer | 28/01/2003 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Biomedical Diagnostics NV
Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Distribution Services |
- Stock Market
- Insiders
- Fabienne Steens